J0834 HCPCS code: Injection, cosyntropin, 0.25 mg
J0834 is the HCPCS Level II code for injection, cosyntropin, 0.25 mg. In 2024 Medicare paid an average of $18.84 per service for J0834 across 3,063 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 3 per day on outpatient hospital claims. Medicare volume fell 4% from 2022 to 2024 (3,190 to 3,063 services). In 2024, about 1,361 clinicians billed Medicare for J0834 for 2,866 beneficiaries; California, North Carolina, Texas accounted for 30% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2010-01-01 |
| Last action effective | 2019-01-01 |
Who bills J0834 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 1,361 |
| Medicare beneficiaries | 2,866 |
| States with claims | 38 |
| Share of services in top 3 states (California, North Carolina, Texas) | 30% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J0834, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 3,190 | 3,004 | $29.55 | $22.38 |
| 2023 | 3,171 | 2,947 | $26.59 | $20.30 |
| 2024 | 3,063 | 2,866 | $24.85 | $18.84 |
States with the most J0834 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| California | 392 | $18.73 |
| North Carolina | 261 | $18.61 |
| Texas | 252 | $19.13 |
| Arizona | 171 | $18.86 |
| New York | 150 | $19.95 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 3 | Prescribing Information |
| practitioner claims | 3 | Prescribing Information |
What changed for J0834
- 2010-01-01: J0834 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J0834?
J0834 is the HCPCS Level II code for injection, cosyntropin, 0.25 mg. Short descriptor: "Inj., cosyntropin, 0.25 mg".
How much does Medicare pay for J0834?
In 2024, the average Medicare payment was $18.84 per service (average allowed $24.85).
Does Medicare cover J0834?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J0834 can be billed per day?
3 on outpatient hospital claims; 3 on practitioner claims (NCCI medically unlikely edits).
Related J08 codes
- J0800 — Injection, corticotropin, up to 40 units
- J0801 — Injection, corticotropin (acthar gel), up to 40 units
- J0802 — Injection, corticotropin (ani), up to 40 units
- J0833 — Injection, cosyntropin, not otherwise specified, 0.25 mg
- J0840 — Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram
- J0841 — Injection, crotalidae immune f(ab')2 (equine), 120 mg
- J0850 — Injection, cytomegalovirus immune globulin intravenous (human), per vial
- J0870 — Injection, imetelstat, 1 mg
- J0871 — Injection, daptomycin (endo), not therapeutically equivalent to j0878, 1 mg
- J0872 — Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg
- J0873 — Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg
- J0874 — Injection, daptomycin (baxter), not therapeutically equivalent to j0878, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J0834
- Watch J0834 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J0834
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.